Stock Picks


  • Stock Pops & Drops: DPZ, OWW, DSW, CREE     Tuesday, 17 Jun 2014 | 5:45 PM ET

    The Fast Money traders take a look at today's biggest market movers.

  • Reynolds push into e-cigs     Tuesday, 17 Jun 2014 | 5:40 PM ET

    Bonnie Herzog, Wells Fargo, discusses what Reynolds American's Vuse distribution means for the industry. Herzog also explains why she thinks CNBC's David Faber is wrong about a deal between Lorillard and Reynolds.

  • Housing sector no place to be: Trader     Tuesday, 17 Jun 2014 | 5:30 PM ET

    FM trader Steve Grasso makes the case for KB Home's valuation and which level the stock would be a buy. Brian Kelly explains why he does not want to be in housing.

  • Amazon threat to iPhone?     Tuesday, 17 Jun 2014 | 5:15 PM ET

    Brian Marshall, ISI Group, compares the impact of Amazon's smartphone to the minimal effect the Kindle had on iPad sales.

  • Pavel Molchanov, Raymond James, discusses the production of solar panels and weighs in on SolarCity's acquisition of Silevo.

  • Battery supply and demand     Tuesday, 17 Jun 2014 | 5:05 PM ET

    Andrea James, Dougherty and Company vice president, weighs in on battery supply and how Elon Musk's Gigafactory will disrupt the industry. The FM crew trades the stock.

  • Yellen's 'tricky' situation: Trader     Tuesday, 17 Jun 2014 | 5:00 PM ET

    The best way to trade current market volatility and inflation, with the "Fast Money" crew.

  • Will Iraq be the trigger for a market correction? Tuesday, 17 Jun 2014 | 2:10 PM ET
    Tribesmen, fighting alongside Iraqi police forces, hold a position in a street of the city of Ramadi, west of the capital Baghdad, on January 30, 2014 during a military operation against anti-government fighters.

    Rising tensions in Iraq are giving investors anxiety. Is this the trigger for a correction? NYSE floor trader Kenny Polcari weighs in.

  • BofAML Technician: Short copper now     Tuesday, 17 Jun 2014 | 1:12 PM ET

    MacNeil Curry, head of global technical strategy at Bank of America Merrill Lynch, says it's time to sell against the recent strength in copper. With CNBC's Jackie DeAngelis and the Futures Now Traders.

  • BofAML Chartist: Short copper again     Tuesday, 17 Jun 2014 | 1:10 PM ET

    The case against copper and the outlook for industrial metals. Trading copper now, with MacNeil Curry, Bank of America Merrill Lynch, CNBC's Jackie DeAngelis and the Futures Now Traders.

  • Marc Faber: Fed's policies a 'catastrophe'     Tuesday, 17 Jun 2014 | 1:07 PM ET

    Marc Faber, editor and publisher of the Gloom, Boom & Doom Report, still thinks the Fed is painting itself into a corner, with CNBC's Jackie DeAngelis and the Futures Now Traders.

  • What the Fed means for bonds     Tuesday, 17 Jun 2014 | 1:05 PM ET

    Is there a Fed shocker ahead? The next move for rates, with CNBC's Jackie DeAngelis and the Futures Now Traders.

  • Marc Faber: Blame the media for gold's demise     Tuesday, 17 Jun 2014 | 1:02 PM ET

    Marc Faber, the editor and publisher of the Gloom, Boom & Doom Report, explains why gold's decline from its highs can be blamed on the financial press, with CNBC's Jackie DeAngelis and the Futures Now Traders.

  • Marc Faber takes on the Fed     Tuesday, 17 Jun 2014 | 1:00 PM ET

    The Fed meeting begins. What Marc Faber, The Gloom, Boom & Doom Report, likes now and where he sees the market headed. With CNBC's Jackie DeAngelis and the Futures Now Traders, Jim Iuorio and Jeff Kilburg, both from the CME.

  • Link's 2nd half picks: AWI, IR & JCI     Tuesday, 17 Jun 2014 | 12:47 PM ET

    FMHR trader Stephanie Link is very encouraged by industrial production data in the U.S. She explains her investment strategy for the second half of the year.

  • 'Lots of reasons' to be careful here: Cramer Tuesday, 17 Jun 2014 | 12:22 PM ET
    Jim Cramer on "Squawk on the Street."

    Disappointing economic data have only added to concerns, CNBC's Jim Cramer says.

  • GW Pharmaceuticals is developing effective treatments based on chemical cannabinoids found in marijuana to treat seizures. CNBC's Jim Cramer looks at reports of promising results from its drug Epidiolex.

  • Cramer: This 'cult stock' goes higher Tuesday, 17 Jun 2014 | 9:43 AM ET
    CNBC's Jim Cramer.

    "It's the animal-spirited stock of this moment," CNBC's Jim Cramer says.

  • Cramer's Mad Dash: Netflix comes back     Tuesday, 17 Jun 2014 | 9:28 AM ET

    Jim Cramer explains what to watch ahead of the open, including an upgrade for Netflix.

  • Cramer: Starbucks subtly boosts long-term value? Monday, 16 Jun 2014 | 6:53 PM ET

    CEO Howard Schultz just made a clever move that should drive shareholder value much further over the long-run.